Predicting extrathyroidal extension in papillary thyroid carcinoma using a clinical-radiomics nomogram based on B-mode and contrast-enhanced ultrasound
L Jiang, S Guo, Y Zhao, Z Cheng, X Zhong, P Zhou - Diagnostics, 2023 - mdpi.com
Papillary thyroid carcinoma (PTC) is the most common pathological type of thyroid cancer.
PTC patients with extrathyroidal extension (ETE) are associated with poor prognoses. The …
PTC patients with extrathyroidal extension (ETE) are associated with poor prognoses. The …
Recent advances in papillary thyroid carcinoma: Progression, treatment and survival predictors
EM Volpi, MC Ramirez-Ortega… - Frontiers in Endocrinology, 2023 - frontiersin.org
Papillary Thyroid Carcinoma: Progression, Treatment and Survival Predictors, several
reports are gathered with a common aim, which is the etiopathogenic mechanisms that …
reports are gathered with a common aim, which is the etiopathogenic mechanisms that …
Bilaterality as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma
H Kim, H Kwon - Cancers, 2023 - mdpi.com
Simple Summary About 30% of thyroid cancer is found on both thyroid lobes simultaneously.
However, the prognostic effect of bilaterality remains unestablished and controversial. This …
However, the prognostic effect of bilaterality remains unestablished and controversial. This …
[HTML][HTML] Vascularity depicted by contrast-enhanced ultrasound predicts recurrence of papillary thyroid cancer
W Li, Y Li, M Long, J Li, J Ma, Y Luo - European Journal of Radiology, 2023 - Elsevier
Purpose Although angiogenesis is crucial for the occurrence and development of solid
tumors, the prognostic value of vascularity remains unclear in papillary thyroid cancer (PTC) …
tumors, the prognostic value of vascularity remains unclear in papillary thyroid cancer (PTC) …
Recurrent Middle Eastern Differentiated Thyroid Carcinoma Has Worse Outcomes Than Persistent Disease
SK Parvathareddy, AK Siraj… - Journal of Clinical …, 2024 - mdpi.com
Background: Despite the excellent prognosis of differentiated thyroid carcinoma (DTC),
recurrent and persistent disease remain major challenges. Emerging studies to differentiate …
recurrent and persistent disease remain major challenges. Emerging studies to differentiate …
[HTML][HTML] Unexpected 99mTc-pertechnetate avidity of lymph node metastases predicts better response to radioiodine therapy in differentiated thyroid cancer patients …
J Liu, X Li, L Li, Y Yin, H Cai, H Yi - American Journal of Nuclear …, 2024 - ncbi.nlm.nih.gov
Objective: To investigate the value of 99m Tc-pertechnetate scan in postoperative
differentiated thyroid cancer (DTC) patients with lymph node (LN) metastases (LNM) uptake …
differentiated thyroid cancer (DTC) patients with lymph node (LN) metastases (LNM) uptake …
Relationship of Recurrence Rate with some Characteristics in Patients with Thyroid Carcinoma
BDM Tri, BDP Chi, BT Hiep, NH Trung… - Indian Journal of …, 2023 - journals.lww.com
Background: Determining the clinical and subclinical characteristics related to the
recurrence status in patients with a thyroid carcinoma has great significance for prognosis …
recurrence status in patients with a thyroid carcinoma has great significance for prognosis …